Results 21 to 30 of about 1,793 (169)
Platelet-rich plasma efficacy in alopecia areata patients with normal and elevated levels of antibodies against thyroglobulin and thyroid peroxidase [PDF]
Folia MedicaAim: To evaluate and compare the efficacy of platelet-rich plasma (PRP) therapy in alopecia areata (AA) patients with normal and with elevated levels of anti-thyroglobulin antibodies and/or anti-thyroid peroxidase antibodies.
Tsvetana I. Abadjieva +3 more
doaj +3 more sources
Przegląd Dermatologiczny, 2023 The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska +8 more
doaj +1 more source
Siriraj Medical Journal, 2017 Background: Alopecia totalis (AT) and alopecia universalis (AU) have a high rate of recurrence and are very difficult to treat. To date, no consensus has been reach among clinicians regarding the best way to treat these conditions.
Rattapon Thuangtong
doaj +3 more sources
Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
Case Reports in Endocrinology, 2021 Autoimmune polyglandular syndrome type 1 (APS1) is a progressive life-threatening illness with no known cure. Current treatments involve replacement of the hormone deficiencies that result from autoimmune destruction of multiple endocrine organs.
Jill D. Jacobson +3 more
doaj +1 more source
Efficacy of Trichloroacetic Acid in Patients with Alopecia Areata: A Clinico-Histopathological Study [PDF]
International Journal of Medical Arts, 2023 Background: Alopecia areata is an autoimmune disorder caused by a breakdown in the follicular immune privilege system, resulting in non-scarring hair loss. Many therapeutic options have been tested with variable results.
Hossam Anter +3 more
doaj +1 more source
PUVA treatment of alopecia totalis
Acta Dermato-Venereologica, 1983 40 patients with alopecia totalis have been treated with PUVA. 26 did not respond, 6 experienced a partial hair regrowth, while 8 got a complete regrowth. However, relapses were frequent, occurring at an early stage.
O, Larkö, G, Swanbeck
openaire +2 more sources
Is Alopecia a Clinical Symptom in Kawasaki Disease? [PDF]
Journal of Kerman University of Medical Sciences, 2014 A 20-months-old infant was admitted with prolonged fever, bilateral non-purulent conjunctivitis, strawberry tongue, lip cracking and maculopapular rash. Left branch coronary aneurysm formation was detected in Color-Doppler echocardiography. The diagnosis
Mohammad Mehdi Bagheri +3 more
doaj
A patient with rickets and alopecia totalis
Journal of Clinical and Scientific Research, 2023 Abstract Rickets is a disorder of bone mineralisation. Common causes of rickets are dietary calcium and Vitamin deficiency. Mutations in vitamin D activity are known to cause Vitamin D-resistant rickets (VDRRs). Various types of VDRRs have been identified – type I and type II along with their subtypes.
Shanthisree Edara +5 more
openaire +1 more source
Dermatology and Therapy, 2020 Introduction Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes.
Joanna Nowaczyk +4 more
doaj +1 more source
Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
Dermatology Research and Practice, 2023 Background. Alopecia areata (AA) is a common form of noncicatricial hair loss of unknown cause, affecting 0.1-0.2% of the general population. Most evidence supports the hypothesis that it is disease of the hair follicle of autoimmune nature mediated by T-
Zainab A. Kamil +2 more
doaj +1 more source